Skip to main content
. 2023 Feb 7;14(2):90. doi: 10.1038/s41419-022-05547-5

Fig. 5. PDHB-AS recruits PABPC1 to modulate Wnt7b expression.

Fig. 5

A, B The mRNA and protein levels of Wnt7b were measured respectively by RT-qPCR and western blot after miR-582-5p overexpression. C PABPC1 and RBMX were ascertained to bind to PDHB-AS by RNA pull down assays and mass spectrometry, followed by western blot to detect PABPC1 and RBMX protein levels precipitated in PDHB-AS sense/antisense, with input as a positive control. D, E In RIP assay, the relative enrichment of PDHB-AS and Wnt7b in anti-PABPC1 and anti-RBMX groups was detected via RT-qPCR, with IgG as a negative control. F, G The mRNA and protein levels of Wnt7b were examined respectively by RT-qPCR and western blot after knockdown of PABPC1. H In RIP assay, the relative enrichment of PDHB-AS or Wnt7b precipitated in anti-PABPC1 was measured in cells transfected with pcDNA3.1 or pcDNA3.1-PDHB-AS, respectively. I, J RT-qPCR and western blot analyses of Wnt7b levels were performed in HeLa and SiHa cells transfected with pcDNA3.1, pcDNA3.1-PDHB-AS, pcDNA3.1-PDHB-AS + si-NC, or pcDNA3.1-PDHB-AS + si-PABPC1. **P < 0.01, n.s.: no significance.